Featured

30 April 2024

The MM+M Agency 100 report: Oxford PharmaGenesis is recognized as an industry leader for the fourth year running

For the fourth year running, media brand Medical Marketing and Media (MM+M) has listed Oxford PharmaGenesis in its Agency 100 report – the annual definitive ‘who’s who’ ranking of the healthcare sector’s top marketing firms in North America.

All
  • All
  • News
  • Articles
  • Events

Oxford PharmaTrotters run (more than) a marathon for Sport Relief

Yesterday, Oxford PharmaGenesis really went the extra mile to raise money for Sport Relief. Our keen trotters ran a total of 32.5 miles over courses in Tubney, Oxfordshire, Trafalgar Square, London, and Newtown, PA, USA, and raised more than £300.

Continue reading

Oxford PharmaGenesis highlights patient centricity in publication practice: report from TIPPA's 15th Annual Meeting

Multiple aspects of HealthScience – including rare diseases, real-world evidence, and health economics and outcomes research – were major topics for discussion at the 15th Annual Meeting of The International Publication Planning Association (TIPPA) last week, sponsored by Oxford PharmaGenesis. The meeting, held in San Diego on 29 February–1 March 2016, was attended by a…

Continue reading

Oxford PharmaGenesis research creates a buzz

Our research demonstrating the value of professional medical writing support has gained remarkable online attention since publication last week in BMJ Open. Based on a combination of online attention and sharing on social media, our article has achieved an Altmetric score of 52, putting it in the top 5% of all research outputs scored by…

Continue reading

SURE™ real-world data source assessments expand into new therapy areas

Oxford PharmaGenesis this week expanded its real-world evidence experience into the areas of respiratory and infectious diseases, with the commissioning of two new SURE™ (Systematic Understanding of Real-World Evidence) assessments. This brings to double digits the number of SURE™ projects initiated in the past 12 months, which have covered cardiology, neurology, diabetes, endocrinology, oncology, immunology…

Continue reading

Oxford PharmaGenesis study shows that professional medical writers strengthen research reporting

Professional medical writing support improves the quality of clinical trial reporting, according to a new study conducted by Oxford PharmaGenesis and published in BMJ Open today. The research shows that compliance with reporting guidelines in medical journal articles almost doubles when medical writers are involved. The quality of written English is also significantly improved with…

Continue reading

Helping the fight against Batten disease – with festive cake, woolly jumpers, curry, a raffle and a quiz

“If you imagine the symptoms of Alzheimer’s disease, Parkinson’s disease, motor neurone disease and epilepsy all rolled in to one, it gives you a good idea of how a child with neuronal ceroid lipofuscinosis (NCL) is affected,” says Kim Wager, Associate Consultant at Oxford PharmaGenesis. “Currently, there are no effective therapies, so obtaining research funding…

Continue reading